论文信息 - Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial. - 字舞流文

Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial.

D. Huscher | G. Burmester | A. Radbruch | G. Riemekasten | F. Hiepe | E. Feist | B. Sawitzki | E. Siegert | J. Humrich | P. Enghard | B. Stuhlmüller | T. Alexander | A. Rose | C. von Spee-Mayer | D. Abdirama | M. Bertolo | Caroline von Spee-Mayer | D Abdirama